Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Forman, S. J.
Right arrow Articles by Blume, K. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Forman, S. J.
Right arrow Articles by Blume, K. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Bone marrow ablation followed by allogeneic marrow grafting during first complete remission of acute nonlymphocytic leukemia

SJ Forman, WE Spruce, MJ Farbstein, JL Wolf, EP Scott, AP Nademanee, JL Fahey, T Hecht, JA Zaia, RA Krance, DO Findley and KG Blume

Of 33 patients who had undergone allogeneic bone marrow transplantation during first complete remission of acute nonlymphocytic leukemia, 21 patients have now been followed in continued complete remission for 6- 64 mo (median greater than 18 mo) without maintenance chemotherapy. The median age of the surviving patients is 27 yr. Transplant-related complications occurring throughout the first year after marrow grafting were fatal in 7 patients, and leukemic recurrence led to the death of 5 patients. The actuarial long-term disease-free survival is 60% and the actuarial remission rate is 79%.

Volume 61, Issue 3, pp. 439-442, 03/01/1983
Copyright © 1983 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 ANN INTERN MEDHome page
J. D. PIRSCH and D. G. MAKI
Infectious Complications in Adults with Bone Marrow Transplantation and T-Cell Depletion of Donor Marrow: Increased Susceptibility to Fungal Infections
Ann Intern Med, May 1, 1986; 104(5): 619 - 631.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
R. E. CHAMPLIN, W. G. HO, R. P. GALE, D. WINSTON, M. SELCH, R. MITSUYASU, C. LENARSKY, R. ELASHOFF, J. ZIGHELBOIM, and S. A. FEIG
Treatment of Acute Myelogenous Leukemia: A Prospective Controlled Trial of Bone Marrow Transplantation Versus Consolidation Chemotherapy
Ann Intern Med, March 1, 1985; 102(3): 285 - 291.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
F. R. APPELBAUM, S. DAHLBERG, E. D. THOMAS, C. D. BUCKNER, M. A. CHEEVER, R. A. CLIFT, J. CROWLEY, H. J. DEEG, A. FEFER, P. D. GREENBERG, et al.
Bone Marrow Transplantation or Chemotherapy After Remission Induction for Adults with Acute Nonlymphoblastic Leukemia: A Prospective Comparison
Ann Intern Med, November 1, 1984; 101(5): 581 - 588.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
R. P. GALE
Progress in Acute Myelogenous Leukemia
Ann Intern Med, November 1, 1984; 101(5): 702 - 705.
[Abstract] [PDF]


click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1983 by American Society of Hematology         Online ISSN: 1528-0020